CCO Oncology Podcast

189 Epizód

1. BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

   Közzétéve: 2023. 04. 05.
2. Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers

   Közzétéve: 2023. 03. 28.
3. Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts

   Közzétéve: 2023. 02. 23.
4. FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia

   Közzétéve: 2023. 02. 20.
5. Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

   Közzétéve: 2023. 02. 17.
6. Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

   Közzétéve: 2023. 02. 17.
7. Individualizing Care for Patients With Triple-Negative Breast Cancer

   Közzétéve: 2023. 01. 18.
8. Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

   Közzétéve: 2023. 01. 11.
9. HCC Surveillance: Challenges and Opportunities

   Közzétéve: 2023. 01. 03.
10. A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

    Közzétéve: 2022. 12. 13.
11. Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

    Közzétéve: 2022. 11. 29.
12. The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System

    Közzétéve: 2022. 11. 29.
13. Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

    Közzétéve: 2022. 11. 09.
14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

    Közzétéve: 2022. 10. 28.
15. Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting

    Közzétéve: 2022. 10. 24.
16. Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

    Közzétéve: 2022. 10. 24.
17. Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer

    Közzétéve: 2022. 10. 04.
18. Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions

    Közzétéve: 2022. 09. 28.
19. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

    Közzétéve: 2022. 08. 30.
20. Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

    Közzétéve: 2022. 08. 22.